Evidence map›Paper›PMID 30957165›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States.

Keith S Kaye, Lindsay A Petty, Andrew F Shorr, Marya D Zilberberg

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epidermicin NI01 demonstrates potentJAC-antimicrobial resistance · 2026
    Article
  12. Observational
  13. Methicillin-ResistantOpen forum infectious diseases · 2026
    Review
  14. Microbiology spectrum · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Keith S KayeDivision of Infectious Diseases, University of Michigan Medical School, Ann Arbor.
Lindsay A PettyDivision of Infectious Diseases, University of Michigan Medical School, Ann Arbor.
Andrew F ShorrHealth Services Research, Washington Hospital Center, Washington, DC.
Marya D ZilberbergDivision of Pulmonary and Critical Medicine, EviMed Research Group, LLC, Goshen.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The US burden of acute skin infections is substantial. While Staphylococcus aureus and Streptococcus spp. are the most common causes, gram-negative bacteria and mixed infections can occur in some settings. These mixed infections are more likely to result in inappropriate empiric antibiotic therapy. Important challenges remain in diagnosing and treating acute skin infections.

Indexed as

Cost of IllnessAcute DiseaseAnti-Bacterial AgentsDisease ManagementDisease SusceptibilityHumansPublic Health SurveillanceRisk FactorsSkin Diseases, BacterialSoft Tissue InfectionsTreatment OutcomeUnited StatesAnti-Bacterial Agentsacute bacterial skin and skin structure infectionsburdenepidemiologyetiologyUnited States

Identifiers

PMID30957165
PMCPMC6452002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.